Symbols

MBRX

Moleculin Biotech·NASDAQ

--(--)

7.47 / 10

Outperform

Sentiment is upbeat with a 7.47 score and fund‑flow rating good (7.68). Small investors show positive inflow, while larger blocks are net outflows. Analyst coverage is limited but fully bullish (100% Strong Buy). Overall confidence is positive despite mixed flow patterns.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

100%

Buy

Hold

Sell

Strong Sell

Date2026-03-24

InstitutionHC Wainwright & Co.

Times predicted4

Historical Win Rate50.0%

What is the analyst consensus for MBRX?

MBRX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.47/10 (Outperform).